Julian Rydzek
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Biomedical Engineering top 10%
- Genetics top 10%
- Co-authors
- Michael HudecekHermann EinseleThomas NerreterTheodoros GiavridisMichel SadelainKatrin MestermannSilke FrenzJustus Weber
- Topics
- CAR-T cell therapy research (7 papers)Virus-based gene therapy research (2 papers)Immune Cell Function and Interaction (2 papers)
- Cited by
- OncologyImmunologyHematology
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Julian Rydzek
7 papers receiving 843 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Oncology 741
- Molecular Biology 300
- Immunology 287
- Biomedical Engineering 265
- Genetics 205
Countries citing papers authored by Julian Rydzek
This map shows the geographic impact of Julian Rydzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Rydzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Rydzek more than expected).
Fields of papers citing papers by Julian Rydzek
This network shows the impact of papers produced by Julian Rydzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Rydzek. The network helps show where Julian Rydzek may publish in the future.
Co-authorship network of co-authors of Julian Rydzek
This figure shows the co-authorship network connecting the top 25 collaborators of Julian Rydzek. A scholar is included among the top collaborators of Julian Rydzek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Rydzek. Julian Rydzek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 92 | |
| 2 | The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cellsbreakdown → | 379 |
| 3 | 1 | |
| 4 | 153 | |
| 5 | 40 | |
| 6 | 1 | |
| 7 | 184 |
About Julian Rydzek
Julian Rydzek is a scholar working on Oncology, Immunology and Genetics, having authored 7 papers that have together received 850 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (741 citations), Immunology (287 citations) and Hematology (149 citations). Julian Rydzek has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Michael Hudecek, Hermann Einsele, Thomas Nerreter, Theodoros Giavridis, Michel Sadelain, Katrin Mestermann, Silke Frenz, Justus Weber, Andreas Mades and Martin Schreder. Their work appears in journals such as Blood, Nature Immunology and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.